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Abstract 
Purpose: To investigate the protective effects of plumbagin against liver fibrosis and explore the influence of 
plumbagin on the proliferation of hepatic stellate cells (HSCs).  
Methods: HSC-LX2 cells were divided into blank/control group, 100 ng/ml leptin group, 100 ng/ml leptin + 2 
µmol/L plumbagin group, 100 ng/ml leptin + 8 µmol/L plumbagin group and 100 ng/ml leptin + 6.25 µg/ml 
colchicines group. The expressions of leptin receptor protein (OB-Rb), p-JAK2, p-STAT3, JAK2, STAT3, p-
ERK1/2, ERK1/2 and MMP-1 were detected by Western blot assay. The content of type I collagen in the 
supernatant of HSCs was also measured after stimulation by leptin. 
Results: Leptin induced OB-Rb expression in HSCs, which reached a peak level at 24 h (p < 0.01). Leptin-
induced OB-Rb expression was significantly inhibited by plumbagin at concentrations of 2 µmol/L and 8 
µmol/L, respectively. Western blot assay revealed that plumbagin significantly decreased pJAK2 expression 
in leptin-treated HSCs (p < 0.01). Leptin induced expression of pSTAT3 significantly decreased after 
plumbagin treatment in HSC-LX2 (p < 0.01). p-ERK1/2 expression markedly decreased in plumbagin-treated 
HSCs (p < 0.01). Plumbagin significantly increased MMP-1 expression in leptin-treated HSCs (p < 0.01). 
Conclusion: Plumbagin has an anti-fibrotic effect and may decrease the protein expressions of components 
in JAK2-STAT3 pathway to inhibit HSC proliferation. Thus, plumbagin may be useful in the clinical prevention 
and treatment of liver fibrosis. 
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Hepatic fibrosis, characterized by abnormal 
accumulation of extracellular matrix (ECM), is a 
wound-healing process responsive to a variety of 
factors, such as cytokines, growth factors, and 
inflammatory mediators. Previous studies have 
showed that ECM is mainly derived from hepatic 
stellate cells (HSCs) in the process of hepatic 
fibrosis[1,2]. Activation of resident HSCs into 
proliferative, contractile, and fibrogenic cells is a 
dominant cause of liver injury.  
 
Recently, evidence suggests a critical role of 
leptin in the hepatic inflammation and 
fibrogenesis [3]. When chronic liver injury occurs, 
leptin augments net production of extracellular 
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matrix (ECM) by increasing HSC proliferation, 
elevating type I collagen synthesis and tissue 
inhibitor of metalloproteinase 1 (TIMP-1), and 
strongly inhibiting the apoptosis of HSCs [4, 5]. In 
HSCs, leptin binds to the long form leptin 
receptor, Ob-Rb, and activates Janus kinase 
2(JAK2)/signal transducer and activator of 
transcription 3 (STAT3)  pathway, leading to the 
enhanced synthesis and secretion of collagen 
and increased ECM deposition. In recent years, 
a large number of clinical and experimental 
studies have demonstrated that leptin is closely 
related to liver fibrosis.  
 
This study was undertaken to investigate the 
effect of plumbagin on the activation of signal 
molecules in HSCs. Our finding may elucidate 
the potential mechanism underlying the 
protective effect of plumbagin on hepatic fibrosis 
and uncover more targets for inhibiting leptin-
induced HSC activation, thus possibly providing 
evidence and method for clinical prevention and 




Cell lines, reagents and antibodies 
 
LX-2 cells, an immortalized human hepatic 
stellate cell line, were provided by the Medical 
Experimental Center of Xiangya Medical College. 
Plumbagin was purchased from Sigma. 
Recombinant leptin was obtained from Protech. 
Rabbit monoclonal anti-OB-R antibody was from 
Bioworld (USA). Rabbit polyclonal anti-JAK2 
antibody and rabbit polyclonal anti-phospho-
JAK2 antibody were from Bioss (USA). Rabbit 
monoclonal anti-STAT3, anti-phospho-STAT3, 
anti-ERK1/2, anti-phospho-ERK1/2, anti-MMP-1, 
anti-MMP-13 and anti-collagen antibodies were 
obtained from Bioworld (UK). 
 
Enzyme-linked immunosorbent assay (ELISA) 
 
In brief, 2 mL of HSCs suspension was seeded 
into 6-well plates at 1×105 cells/mL and cultured 
at 37 oC in a humidified atmosphere with 5 % 
CO2 for 2 h. Cells were treated with 100 ng/mL 
leptin, 100 ng/mL leptin plus 2 µmol/L plumbagin, 
100 ng/mL leptin plus 8 µmol/L plumbagin, 100 
ng/mL leptin plus 6.25 g/ml colchicine, 
respectively. HSCs without treatment served as 
the negative control group, and those treated 
with 100 ng/mL leptin plus colchicine as the 
positive control group., The content of type I 
collagen in the supernatant of HSCs was 




HSC-LX2 cells were incubated in high-glucose 
Dulbecco's Modified Eagle Medium  (DMEM) 
supplemented with 2 mM L-glutamine, 100 U/mL 
penicillin, 100 µg/mL of streptomycin, 50 µM 2-
Mercaptoethanol (2-ME), and 10 % fetal calf 
serum (FCS; all from Life Technologies, 
Invitrogen, USA) at 37 oC in a humidified 
incubator with 5 % CO2. Cells were trypsinized, 
washed and cultured in 6-well plates (Corning, 
NY) at 5×104 cells/mL in duplicate. After 24 h, 
leptin was added to corresponding wells and the 
expressions of target proteins were detected at 
0, 6, 12, 24, 36 and 48 h.  
 
SDS-PAGE and Western blot assay 
 
Western blot assay was performed as described 
before [6]. Cells were collected and washed 
twice with cold phosphate buffered saline (PBS). 
Then, these cells were lysed with radio-
immunoprecipitation assay (RIPA) Lysis Buffer 
(50 mmol/L Tris, 1 % NP-40, 150 mmol/L NaCl, 1 
mmol/L ethylenediaminetetraacetic acid (EDTA), 
0.1% SDS). The proteins were quantified using 
the Bradford method. Proteins were subjected to 
sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE) and then 
transferred electrophoretically onto a 
nitrocellulose membrane. The membrane was 
blocked with 5% non-fat milk in Tris Buffered 
Saline with Tween (TBST) (50 mmol/L Tris-HCl, 
150 mmol/L NaCl and 0.1 % Tween), and then 
incubated with rabbit monoclonal antibody 
against OB-Rb, phosphor-JAK2, phosphor-
STAT3, JAK2, STAT3, phosphor-ERK1/2, 
ERK1/2, MMP-1, MMP-13 or gyceraldehyde 3-
phosphate dehydrogenase(GAPDH). The goat 
anti-rabbit IgG antibody conjugated to 
horseradish peroxidase was used as a 
secondary antibody. The resulting bands were 
detected using an enhanced chemiluminescence 
detection system according to the manufacturer’s 
instructions. GAPDH was used as an internal 
reference and three independent experiments 




All experimental data were analyzed by SPSS 
version 13.0 and expressed as mean ± standard 
deviation (SD). Data among groups were 
compared using analysis of variance and those 
between groups by Student t test. A value of p < 
0.05 was considered statistically significant. 
Detection of optical density of each band and 
image analyses were performed using Quantity 
One 4.62 analysis software. 
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Effect of leptin and plumbagin on OB-Rb 
expression  
 
As shown in Figure 1A, leptin induced OB-Rb 
expression in HSCs, which reached a peak level 
at 24 h (P<0.01) (Figure 1C). The OB-Rb 
expression increased in a time dependent 
manner within 36 h. However, OB-Rb expression 
gradually decreased to baseline level at 48 h. 
 
Based on the above results, cells were then 
treated with 100 ng/mL leptin for 24 h to induce 
OB-Rb expression. As shown in Figure 1 B&D, 
leptin induced OB-Rb expression was 
significantly inhibited by plumbagin at 2 µmol/L 
and 8 µmol/L. Untreated cells were used as a 
negative control group and cells treated with 100 
ng/mL leptin alone as a positive control group.  
 
Effect of leptin and plumbagin on JAK2 
activation in HSC-LX2   
 
As shown in Figures 2A and B, phosphorylated 
JAK2 was detected at different time points after 
leptin treatment. After leptin treatment for 6 h, p-
JAK2 expression in HSCs increased (p < 0.05), 
and reached a peak level at 24 h (p < 0.01). 
Thereafter, p-JAK2 expression decreased 
gradually and was similar to the baseline level at 
48 h. In the study, cells treated with leptin for 24 
h were used as a positive control group. Western 
blot assay revealed that plumbagin significantly 
decreased the pJAK2 and JAK2 expression in 
leptin treated HSCs (p < 0.01), as shown in 
Figure 2C and D. 
 
Effect of leptin and plumbagin on STAT3 and 
pSTAT3 expressions in HSC-LX2    
 
STAT3 plays a key role in many cellular 
processes such as cell growth and apoptosis, 
and mediates the expression of a variety of 
genes in response to stimuli including leptin. 
Thus, the relationship between plumbagin and 
leptin induced expressions of STAT3 and 
pSTAT3 were evaluated in HSC-LX2. As shown 
in Fig. 3A and B, p-STAT3 expression in HSCs 
was enhanced after treatment with leptin for 6 h, 
and reached a peak level at 12 h (p < 0.01). 
Subsequently, p-STAT3 expression decreased, 
and was close to the baseline level at 48 h. As 
expected, plumbagin inhibited the expressions of 
STAT3 and pSTAT3 in leptin-treated HSC-LX2. 
As shown in Fig.3C and D, leptin induced 
expressions of STAT3 and pSTAT3 were 
significantly decreased after plumbagin treatment 
in HSC-LX2.   
  
 
Figure 1: OB-Rb expression in HSC-LX2. A = Western blot assay result; C = relative band expression of OB-Rb 
and GAPDH at different time points; B = Western blot assay after plumbagin treatment; D = relative band 
expressions of OB-Rb and GAPDH after plumbagin treatment; ** p < 0.01 vs blank control. 
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Figure 2: Expressions of JAK2 and pJAK2 in HSC-LX2. A = Western blot assay of pJAK2; B = Expressions of 
pJAK2 and GAPDH at different time points; C = Western blot assay of JAK2 and pJAK2 after plumbagin 
treatment; D = plumbagin treatment significantly reduced pJAK2 and JAK2  expression (p < 0.01); for Figure 2B, 




Figure 3: Expressions of STAT3 and pSTAT3 receptor protein in HSC-LX2: A, Western blot assay of pSTAT3; B, 
Expressions of pSTAT3 and GAPDH at different time points; C, Expressions of STAT3, and pSTAT3 receptor 
protein after plumbagin treatment; D, Plumbagin treatment significantly decreased protein expressions of STAT3 
and pSTAT3 receptor; for Figure 3B, *p < 0.05, **p < 0.01, vs 0 h; for Figure 3D, *p < 0.05, **p < 0.01 vs cells 
treated with leptin alone.  
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Figure 4: Expressions of ERK and pERK in HSC-LX2: A = Western blot assay of pERK; B = expressions of 
pERK and GAPDH at different time points; C = expressions of ERK and pERK after plumbagin treatment; D = 
plumbagin treatment significantly reduced protein expressions of ERK1/2 and pERK1/2; for Figure 4B, *p < 0.05, 
**p < 0.01 vs 0 h; for Figure 4D, *p < 0.05, **p < 0.01 vs cells treated with leptin alone.  
 
Effect of plumbagin on ERK1/2 and pERK1/2 
activation in leptin-treated HSC-LX2 
  
ERK1/2 are members of the mitogen-activated 
protein kinase (MAPK) superfamily that can 
translocate into the nucleus and regulate cell 
proliferation and apoptosis. As shown in 
Fig.4A&B, pERK1/2 expression significantly 
increased in HSC-LX2 after leptin treatment, and 
p-ERK1/2 expression reached a peak level at 12 
h. However, the p-ERK1/2 expression markedly 
decreased in plumbagin-treated HSCs (Figure 
4C and D).  
 
Plumbagin increased MMP-1 production in 
leptin treated HSC-LX2 
 
MMP-1 is also known as interstitial collagenase 
and fibroblast collagenase and an enzyme 
encoded by MMP1 gene in humans. As shown in 
Fig 5A and B, the MMP-1 expression in HSCs 
dramatically decreased after leptin treatment, but 
plumbagin significantly increased MMP-1 
expression in these leptin treated HSCs. 
However, no changes were observed in MMP-13 
expression as shown in western blot assay. 
 
Plumbagin decreased type I collagen content 
of leptin-treated HSC-LX2   
 
The production of type I collagen was also 
measured in the supernatant of HSC-LX2. As 
shown in Figure 5C and D, when compared with 
untreated cells, the content of type I collagen in 
leptin-treated HSC increased significantly (p < 
0.01). However, plumbagin markedly inhibited 
the expression and secretion of type I collagen in 




In 1994, Zhang et al [7] discovered the mouse 
obese gene and its human homologue by 
positional cloning for the first time. Shimamura et 
al [8] synthesized its protein product leptin 
encoded by human and mouse obese gene 
using recombinant DNA technology. The 
discovery of leptin is a major breakthrough in the 
studies on obesity and energy metabolism. 
Leptin, a 16-KDa hormone, is secreted mainly by 
adipocytes and acts on the hypothalamus to 
control body weight by reducing food intake and 
increasing energy consumption [9]. Recently, 
some experiments and clinical studies have 
shown that leptin is closely related to liver fibrosis  
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Figure 5: Expressions of MMP-1, MMP-13 and collagen I in HSC-LX2: A = Western blot assay of MMP-1 and 
MMP-13; B = relative expression of MMP-1, MMP-13 MMP-13 expression remained unchanged (p < 0.01); C = 
expression of collagen I and GAPDH. D = relative expression of collagen I after plumbagin treatment; *p < 0.01, 
**p < 0.01 vs cells treated with leptin alone. 
 
and cirrhosis, and it plays a key role in the 
development of liver fibrosis via inducing HSC 
activation and proliferation.  
 
Leptin has characteristics of some cytokines 
when exerting biological effects, and its biological 
effects require its binding to leptin receptor (OB-
R). OB-R is a member of the class I cytokine 
receptor family, and is composed of a single 
subunit containing extracellular domain, 
transmembrane domain and intracellular 
domain[10,11]. OB-R contains a long chain and a 
short chain, and its biological effects are 
attributed to the activation of the long chain. 
Leptin-induced HSC proliferation is related to the 
activation of JAK-STAT, MAPK and P13K/AKT 
and on the subsequent activation of signal 
transduction pathways[12,13]. JAK/STAT 
signaling is associated with physiological and 
pathological responses, involved in cell 
proliferation, differentiation, functioning and 
apoptosis, and is an important pathway 
mediating cytokine signal transduction[14,15].  
 
JAK-STAT pathway is an important pathway 
related to leptin induced HSC proliferation. OB-R 
lacks intrinsic kinase activity and may mediate 
multiple signaling pathways by binding to 
cytoplasmic kinases such as Janus Kinase 2 
(JAK2). Activation of JAK2 by leptin promotes 
tyrosine phosphorylation of OB-R at Tyr-986, 
Tyr-1078 and Tyr-1141, thus activating OB-R. 
Activation of OB-R by leptin activates signaling 
modules such as JAK/STAT module. Tyrosine 
phosphorylation of OB-R induces the binding of 
STATs to OB-R. Binding of STATs to 
phosphorylated OB-R leads to JAK2 mediated 
tyrosine phosphorylation and STAT activation. 
Activated STATs translocate to the nucleus to 
induce gene expressions, ultimately exerting 
biological effects[16,17].  
 
In vitro studies have found that exogenous leptin 
may significantly stimulate HSC activation [18], 
proliferation and phenotypic change, paralleling 
with type I collagen synthesis. Its activation is 
mainly associated with the activation of signal 
transduction, transcriptional activation factor, 
mitogen-activated protein kinase and 
phosphoinositide-3 kinase. Leptin may promote 
HSC activation and collagen synthesis in these 
cells via activating MAPK signaling pathways. In 
eukaryotic cells, 4 MAPK pathways have been 
identified: ERK1/2, c-jun, p38 and ERK5 
pathways, which play important roles in cell 
growth, development and proliferation. Upon 
activating, ERK enters the nucleus, and 
phosphorylates several transcriptional factors 
(such as c-Myc, ELK, c-jun and c-fos) to regulate 
gene expression [19]. After coupling and 
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activation of JAK tyrosine protein kinase, ERK 
may promote cell proliferation through activating 
ERK1/2 and p38, resulting in hepatic fibrosis 
[19]. 
 
At the early stage of carbon tetrachloride-induced 
hepatic fibrosis, the serum leptin concentration is 
significantly elevated in rats. Due to the key role 
of leptin in the development of liver fibrosis, liver 
fibrosis may be treated by inhibiting or blocking 
leptin activation in HSCs. Our preliminary 
experiments have shown that plumbagin and its 
active ingredients possess protective effects on 
carbon tetrachloride induced liver fibrosis in rats. 
Plumbagin may reduce TGF-β1 in liver fibrosis of 
rats, significantly inhibit the proliferation of HSC-
T6 cells in vitro, and suppress the expressions of 
transforming growth factor β1 and α-smooth 
muscle actin. Many studies have shown that the 
Chinese herbal compound may exert 
pharmacological anti-fibrotic effects at multiple 
levels and multiple targets.  
 
The present study attempts to explore the 
mechanism underlying the anti-fibrotic effect of 
plumbagin at the receptor level. There is 
evidence showing that leptin may affect the 
expression of leptin receptor in hepatocytes and 
influence its phosphorylation. Leptin and its 
receptor may exert a positive regulatory 
feedback, which enables a smoother leptin signal 
transduction and may be better for exerting their 
biological effects [20]. Results from our 
experiments showed that, leptin at optimal 
concentration could induce leptin receptor 
expression in HSCs in a time dependent manner, 
which reached a peak level at 24 h. After 
plumbagin treatment, the OB-Rb expression in 
HSCs was significantly reduced, indicating that 
plumbagin blocks leptin at the receptor level.  
 
The effect of the Chinese herb has multiple 
targets, and thus we hypothesize whether the 
antifibrotic effect of plumbagin is related to the 
blocking of post-receptor signal transduction 
pathways, namely the cytoplasmic or nuclear 
signal transduction process in HSCs. In the 
following experiments, our results showed that 
plumbagin directly blocked the expressions of 
JAK2 and STAT3, the two components of JAK-
STAT signaling pathway. Compared with blank 
control group, leptin significantly increased the 
protein expressions of JAK2, pJAK2, STAT3 and 
pSTAT3. Compared with cells treated with leptin 
alone, plumbagin significantly decreased protein 
expressions of pJAK2, JAK2, STAT3 and 
pSTAT3. This suggests that plumbagin inhibits 
the STAT3 activation at JAK2 phosphorylation 
level, and may inhibit HSC proliferation through 
JAK-STAT signaling pathway. In addition, leptin 
significantly increased ERK1/2 and pERK1/2 
protein expressions, whereas plumbagin 
markedly decreased them, indicating that 
plumbagin also blocks ERK phosphorylation in 
the leptin-dependent MAPK signaling pathway, 
significantly inhibiting the proliferation of HSCs. 
As liver fibrosis occurs, the number of HSCs 
markedly increases, and they undergo a 
phenotypic change into myofibroblasts, resulting 
in production of a large amount of ECM. Upon 
activation, the HSCs presented with a 
myofibroblast-like phenotype: loss of cytoplasmic 
lipid droplets, and increased synthesis of type I 
and type III collagen.  
 
Hepatic fibrosis is characterized by excessive 
deposition of collagens in the cavity of Disse. 
These collagens can be degraded by matrix 
metalloproteinase such as MMP-1. MMP-1 
activity and its physiological inhibitor TIMP-1 
interact with each other. In the process of hepatic 
fibrosis, MMP-1 expression is inhibited but TIMP-
1 expression increased, suggesting that the 
imbalance between MMP-1 and TIMP-1 plays an 
important role in the development of hepatic 
fibrosis. To increase collagenase activity and 
promote ECM degradation are important 
strategies for the clinical treatment of liver 
fibrosis. Studies have shown that [19], leptin may 
stimulate the synthesis of TIMP-1 in HSCs, which 
is dependent on peroxide (H2O2) generation 
(H2O2 can activate ERK1/2, p38, JAK1 and JAK2 
signaling pathway), and may inhibit MMP-1 
expression and increase type I collagen 
expression.  
 
Our findings show leptin treatment could 
significantly reduce MMP-13 expression 
(P<0.01), but had no influence on MMP-1 
expression. Plumbagin treatment for 24 h also 
dramatically increased MMP-1 protein 
expression in HSC-LX2, but MMP-13 remained 
unchanged. Plumbagin can increase the MMP-1 
expression, which is beneficial for ECM 
degradation. In addition, ELISA and western blot 
assays were performed to detect type I collagen 
expression in the supernatant of HSCs. ELISA 
revealed that treatment with plumbagin at 
different concentrations for 24 h inhibited the 
content of type I collagen in the supernatant. 
Western blot assay showed that, when compared 
with control group, 100 ng/mL leptin can 
stimulate the expression and secretion of type I 
collagen in the supernatant of HSCs, whereas 
plumbgin significantly inhibited it in HSCs. This 
suggests that plumbagin may significantly 
enhance collagen degradation, regulate the 
dynamic balance between ECM formation and 
degradation, reduce ECM deposition and 
decrease HSC activation, thereby restoring the 
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normal function of HSCs. Thus, regulating 
collagen synthesis and degradation may be a 




Plumbagin may inhibit leptin-induced proliferation 
of HSC-LX2 cells via blocking JAK-STAT3 and 
JAK-ERK1/2 signaling pathway, and exerting 
anti-fibrotic effects. Currently, there are no ideal 
anti-fibrotic drugs for clinical treatment of hepatic 
fibrosis. Our findings indicate that inhibiting HSC 
activation and proliferation at multiple targets and 
multiple levels may be beneficial for clinical 
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